Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHISX:US

56.87 USD 0.03 0.05%

As of 09:29:30 ET on 05/22/2015.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHISX)

Year To Date: +14.73% 3-Month: +7.12% 3-Year: +33.40% 52-Week Range: 40.59 - 56.90
1-Month: +1.01% 1-Year: +41.02% 5-Year: +24.14% Beta vs SPX: 0.98

Mutual Fund Chart for SHISX

No chart data available.
  • SHISX:US 56.87
  • 1M
  • 1Y
Interactive SHISX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SHISX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 01-28-2005 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHISX

NAV (on 2015-05-22) 56.87
Assets (M) (on 2015-05-21) 5,988.30
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 0.00

Dividends for SHISX

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-12-12) 0.01
Dividend Yield (ttm) 6.04

Fees & Expenses for SHISX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.70
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.20

Top Fund Holdings for SHISX

Filing Date: 03/31/2015
Name Position Value % of Total
Biogen Inc 479,612 202,511,371 3.605%
Celgene Corp 1,684,938 194,239,653 3.458%
Actavis plc 602,052 179,182,716 3.190%
UnitedHealth Group Inc 1,466,194 173,436,088 3.088%
Medtronic PLC 2,133,823 166,416,856 2.963%
Amgen Inc 963,639 154,037,694 2.742%
Bristol-Myers Squibb Co 2,322,400 149,794,800 2.667%
McKesson Corp 630,200 142,551,240 2.538%
Eli Lilly & Co 1,873,600 136,117,040 2.423%
Alexion Pharmaceuticals Inc 751,517 130,237,896 2.319%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil